Dexmedetomidine for prevention of postoperative delirium in patients undergoing craniotomy: a randomized, prospective, placebo-controlled study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044658

Enrollment

Unknown

Registered

2021-03-25

Start date

2021-04-01

Completion date

Unknown

Last updated

2021-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

craniotomy

Interventions

dexmedetomidine group:intravenous infusion dexmedetomidine

control group:Saline placebo

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Craniotomy; 2. Preoperative GCS15; 3. older than 18 years old; 4. informed consent.

Exclusion criteria

Exclusion criteria: 1. Previous central nervous system diseases; 2. Preoperative consciousness changes; 3. drug allergy; 4. Refusal to be included in the study.

Design outcomes

Primary

Measure	Time frame
delirium;	—

Secondary

Measure	Time frame
NICU LOS;	—

Countries

China

Contacts

Public ContactMing-Chao Fan

The Affiliated Hospital of Qingdao University

fanmcchina@126.com+86 17853292728

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026